查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1656913

置入式BCI (布莱恩电脑介面) 设备:市场洞察·竞争情形·市场预测 (～2032年)

Implanted Brain-Computer Interface (BCI) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预测期内，植入式 BCI（脑机介面）设备市场规模预计将以 10.42% 的复合年增长率成长。

植入式 BCI（脑机介面）装置的需求很大程度上受到神经系统疾病和运动障碍盛行率不断上升以及听力和视力丧失患者数量不断增加的推动。此外，数位健康解决方案的日益普及正在重塑病患照护格局，进一步推动市场成长。促成这一上升趋势的关键因素包括加强研发力度以开发更先进的 BCI 设备，以及领先公司之间的策略联盟。预计这些市场发展将在预测期（即 2025-2032 年）内推动植入式 BCI 设备市场发展方面发挥关键作用。

植入式 BCI 装置的市场动态：

神经系统疾病和运动障碍盛行率的不断上升预计将推动植入式 CI 设备市场的成长。根据世界卫生组织（WHO）2024年4月提供的数据，2021年全球将约有1,540万人患有脊髓损伤。

根据英国研究与创新署2022年提供的数据，全球每年约有1,000万人受到创伤性脑损伤的影响。植入式 BCI 装置在评估 TBI 后的脑功能方面发挥重要作用，为了解脑损伤程度提供重要见解并指导治疗决策。此类神经系统疾病的发生率不断上升，对植入式 BCI 设备的需求不断增加，从而推动了市场成长。

根据世界卫生组织（WHO）2024年最新数据，2023年全球将有约5,000万人罹患癫痫，每年诊断出的新病例约500万人。癫痫是世界上最常见的神经系统疾病之一。根据同一数据，到 2023 年将有超过 5,500 万人患有失智症，其中 60% 以上生活在中低收入国家。平均每年有近 1000 万例新诊断的痴呆症病例。植入式 BCI 可以监测大脑活动以检测与癫痫发作相关的异常电模式，提供即时数据，帮助更有效地管理癫痫。此类运动障碍的盛行率不断上升预计将推动市场成长。

此外，听力和视力障碍的日益普遍也有望显着推动植入式 BCI 设备的市场成长。根据世界卫生组织 (WHO) 2023 年 3 月的数据，欧洲有超过 1.9 亿人患有听力损失，预计到 2050 年将超过 2.3 亿人。可植入的 BCI 设备在恢復听力和增强听力体验方面发挥关键作用。随着患有听力损失的人数不断增加，对创新 BCI 设备的需求预计将增长，从而进一步推动市场扩张。

本报告提供全球置入式BCI (布莱恩电脑介面) 设备的市场调查，彙整市场概要，市场影响因素及市场机会分析，法律制度，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 置入式BCI (布莱恩电脑介面) 设备市场报告:简介

  • 调查范围
  • 市场区隔
  • 市场前提条件

第2章 置入式BCI (布莱恩电脑介面) 设备市场:摘要整理

  • 市场概要

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 置入式BCI (布莱恩电脑介面) 设备市场:主要要素分析

  • 推动市场要素
    • 神经系统和运动障碍增多
    • 越来越多的患者出现听力和视力丧失
    • 越来越多采用数位健康解决方案
    • 加强研发活动与主要公司之间的策略合作
  • 市场限制与课题
    • 植入式 BCI 设备相关的併发症和安全问题
    • 设备成本高
  • 市场机会
    • 将人工智慧与嵌入式 BCI 设备结合
    • 微创手术与智慧植入物的出现

第6章 置入式BCI (布莱恩电脑介面) 设备市场:波特的五力分析

第7章 置入式BCI (布莱恩电脑介面) 设备市场评估

  • 各产品
    • 硬体设备
    • 软体
  • 按方法
    • 侵入性BCI
    • 微创BCI
  • 各用途
    • 癫痫
    • 脑损伤
    • 打
    • 中风
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 置入式BCI (布莱恩电脑介面) 设备市场:企业·产品简介

  • NeuroPace, Inc.
  • Blackrock Neurotech
  • Synchron
  • LivaNova, Inc.
  • BrainGate
  • BrainCo, Inc.
  • Cognixion, Inc.
  • Brain Products GmbH
  • Compumedics Neuroscan
  • CorTec
  • Snap Inc.
  • g.tec medical engineering GmbH
  • Bitbrain Technologies
  • Nexstem India Pvt. Ltd.
  • Paradromics
  • CereGate
  • Precision Neuroscience
  • ONWARD Medical N.V.
  • NeuroSky
  • NeuroXess

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明·联络方式

Product Code: DIMDCL0763

Implanted Brain-Computer Interface (BCI) Devices Market by Product (Hardware and Software), Approach (Invasive BCI and Minimally invasive BCI), Application (Epilepsy, Brain Injury, Depression, Stroke, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of neurological and movement disorders and increasing technological innovations in BCI devices

The implanted brain-computer interface (BCI) devices market is estimated to grow at a CAGR of 10.42% during the forecast period from 2025 to 2032. The demand for implanted brain-computer interface (BCI) devices is significantly driven by the increasing prevalence of neurological and movement disorders and a rising number of patients experiencing hearing and vision loss. Additionally, the growing adoption of digital health solutions is reshaping the landscape of patient care, further fueling market growth. Key factors contributing to this upward trend include increasing research and development activities and strategic collaborations among leading players to develop more advanced BCI devices. These developments are expected to play a pivotal role in propelling the implanted BCI devices market during the forecast period from 2025 to 2032.

Implanted Brain-Computer Interface (BCI) Devices Market Dynamics:

The rising prevalence of neurological and movement disorders is poised to drive market growth for implanted brain-computer interface (BCI) devices. The data provided by the World Health Organization (WHO) in April 2024, mentioned that approximately 15.4 million people were living with spinal cord injury in 2021 worldwide.

According to data provided by UK Research and Innovation in 2022, approximately 10 million people are affected by traumatic brain injury every year in the world. Implanted BCI devices play a crucial role in evaluating brain function after TBI, offering vital insights into the extent of brain damage and guiding treatment decisions. This increasing incidence of neurological disorders is creating a heightened demand for implanted BCI devices, thereby propelling market growth.

According to recent data from the World Health Organization (WHO) in 2024, approximately 50 million people worldwide were living with epilepsy in 2023, with around 5 million new diagnoses occurring each year, making epilepsy one of the most common neurological disorders globally. As per the same source in 2023, over 55 million people were living with dementia, with more than 60% of these individuals located in low- and middle-income countries. Each year, nearly 10 million new cases are diagnosed on average. Implanted BCIs can monitor brain activity to detect abnormal electrical patterns associated with seizures, providing real-time data that can help manage epilepsy more effectively. Such increasing prevalence of movement disorders is expected to foster the market growth.

The increasing prevalence of hearing and vision loss is anticipated to significantly drive market growth for implanted brain-computer interface (BCI) devices. According to data from the World Health Organization (WHO) in March 2023, over 190 million people in Europe were living with hearing loss, a figure expected to surpass 230 million by 2050. Implanted BCI devices play a crucial role in restoring hearing, providing individuals with improved auditory experiences. As the number of people affected by hearing loss continues to rise, the demand for these innovative BCI devices is set to grow, further propelling market expansion.

Key players increasingly focus on technological innovations to develop advanced implanted brain-computer interface (BCI) devices that integrate cutting-edge technologies. For instance, in November 2022 Blackrock Neurotech, a U.S. based company launched Neuralace(TM). This next-generation neural interface is engineered with diverse materials and patterns to connect with extensive areas of the brain's surface. Neuralace is designed to perform complex functions without relying on assistive technologies, offering groundbreaking solutions for vision and memory restoration, performance prediction, and the treatment of mental health disorders. Such innovative product developments not only enhance the capabilities of BCI devices but also significantly drive market growth.

However, the complications and safety concerns associated with implanted BCI devices and high cost of BCI devices, among others are some of the key constraints that may limit the growth of the implanted brain-computer interface (BCI) devices market.

Implanted Brain-Computer Interface (BCI) Devices Market Segment Analysis:

Implanted Brain-Computer Interface (BCI) Devices Market by Product (Hardware and Software), Approach (Invasive BCI and Minimally invasive BCI), Application (Epilepsy, Brain Injury, Depression, Stroke, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the implanted brain-computer interface (BCI) devices market, the hardware category is estimated to amass a significant revenue share in the implanted brain-computer interface (BCI) devices market in 2024. This trend can be attributed to the rising incidence of patients suffering from strokes and spinal cord injuries worldwide. According to data from the Centers for Disease Control and Prevention (CDC) published in May 2024, over 795,000 individuals in the United States experience a stroke each year. Implanted BCI hardware such as electrodes and sensors are primarily designed to detect brain signals and facilitate communication between the brain and external devices. These BCIs can significantly assist stroke patients in regaining control over their bodies and improving motor functions. The increasing prevalence of strokes and spinal cord injuries is driving segment growth and contributing to the overall expansion of the implanted brain-computer interface (BCI) devices market.

The growth of the brain-computer interface (BCI) segment can also be attributed to the various advantages offered by the hardware utilized in these devices. BCIs have diverse applications in rehabilitation settings, where they play a crucial role in post-stroke or injury recovery. By promoting neuroplasticity, these devices enable patients to regain motor functions through targeted exercises that are controlled by their thoughts. This capability not only accelerates recovery but also empowers patients by facilitating a more intuitive interaction with their rehabilitation process. As awareness of these benefits grows, the demand for advanced BCI solutions in clinical and therapeutic contexts is expected to expand, further driving market growth.

Moreover, increasing research and development activities aimed at developing innovative implantable BCI devices are significantly fueling market growth. A notable example is Synchron's completion of the COMMAND trial in September 2023, which focused on its brain-computer interface (BCI) devices that received Investigational Device Exemption (IDE) from the FDA. The primary objective of this study was to determine the safety of implanting the device within the blood vessels of the brain using neuro-interventional procedures. Such R&D activities by key players are driving the market growth.

North America is expected to dominate the overall implanted brain-computer interface (BCI) devices market:

North America is expected to account for the largest market share in the implanted brain-computer interface (BCI) devices market in 2024, out of all regions. This can be attributed to the rising prevalence of hearing loss and neurological disorders, alongside a growing geriatric population. Additionally, the increasing healthcare awareness and ongoing technological innovations led by key industry players are significantly driving market growth in North America.

The rising prevalence of neurological disorders is a key factor driving market growth in North America. As per data from the Centers for Disease Control and Prevention (CDC) in September 2023, approximately 6.7 million individuals aged 65 and older were living with Alzheimer's disease in 2023, a number projected to increase to 13.9 million by 2060 in the United States.

According to data from the Centers for Disease Control and Prevention (CDC) published in May 2024, approximately 3 million individuals in the United States were living with epilepsy in 2021. Implanted BCI devices provide innovative solutions for rehabilitation and assistive technologies tailored to the needs of these individuals. Consequently, the increasing prevalence of neurological conditions is driving demand for implanted BCI devices, thereby significantly contributing to market growth in the region.

The increasing geriatric population, which is more susceptible to neurological and motor impairments, is significantly driving market growth in the region. According to data from the Population Reference Bureau published in January 2024, there were approximately 58 million individuals aged 65 and older in the United States in 2022, a number projected to rise to 82 million by 2050. As the global demographic of elderly individuals expands, the demand for implanted BCI devices that address age-related cognitive and mobility decline is also on the rise, thereby propelling the market growth.

The increasing focus on product development and launch activities by key players is significantly fostering market growth. For instance, in May 2024, CorTec announced that the FDA approved an Investigational Device Exemption (IDE) application for its closed-loop brain-computer interface (BCI). This innovative device is designed to support novel stroke rehabilitation treatments by utilizing cortical stimulation to enhance neuroplasticity within the brain. Such product development activities by key players are driving market growth in North America.

Implanted Brain-Computer Interface (BCI) Devices Market Key Players:

Some of the key market players operating in the implanted brain-computer interface (BCI) devices market include NeuroPace, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., BrainGate, BrainCo, Inc., Cognixion, Inc., Brain Products GmbH, Compumedics Neuroscan, CorTec, Snap Inc., g.tec medical engineering GmbH, Bitbrain Technologies, Nexstem India Pvt. Ltd., Paradromics, CereGate, Precision Neuroscience, ONWARD Medical N.V., NeuroSky, NeuroXess, and others.

Recent Developmental Activities in the Implanted Brain-Computer Interface (BCI) Devices Market:

  • In February 2024, Onward Medical secured Breakthrough Device Designation (BDD) from the U.S. Food and Drug Administration (FDA) for its ARC-BCI System. This innovative technology integrates brain-computer interface (BCI) technology with Onward's proprietary ARC-IM(R) Therapy to facilitate thought-driven lower limb mobility restoration in patients with spinal cord injuries (SCI). This designation underscores the potential of the ARC-BCI System to significantly enhance patient outcomes and expedite its development and commercialization process.
  • In May 2023, Neuralink granted an Investigational Device Exemption (IDE) for its N1 Implant. This cutting-edge device is designed to be cosmetically invisible and aimed to record and wirelessly transmit brain signals to a dedicated app that interprets movement intentions. This milestone paves the way for clinical studies and highlights Neuralink's commitment to advancing brain-computer interface technology for enhanced user interaction and mobility.

Key Takeaways from the Implanted Brain-Computer Interface (BCI) Devices Market Report Study

  • Market size analysis for current Implanted Brain-Computer Interface (BCI) Devices Market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Implanted Brain-Computer Interface (BCI) Devices market.
  • Various opportunities available for the other competitors in the Implanted Brain-Computer Interface (BCI) Devices Market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current Implanted Brain-Computer Interface (BCI) Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Implanted Brain-Computer Interface (BCI) Devices market growth in the coming future?

Target Audience who can be benefited from this Implanted Brain-Computer Interface (BCI) Devices Market Report Study

  • Implanted Brain-Computer Interface (BCI) Devices product providers
  • Research organizations and consulting companies
  • Implanted Brain-Computer Interface (BCI) Devices related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Implanted Brain-Computer Interface (BCI) Devices
  • Various end-users who want to know more about the Implanted Brain-Computer Interface (BCI) Devices Market and the latest technological developments in the Implanted Brain-Computer Interface (BCI) Devices Market.

Frequently Asked Questions for the Implanted Brain-Computer Interface (BCI) Devices Market:

1. What are Implanted Brain-Computer Interface (BCI) Devices?

  • Implanted brain-computer interface (BCI) devices represent a cutting-edge neurotechnology, engineered to create a direct communication link between the brain and external systems. These sophisticated solutions typically incorporate surgically implanted electrodes or arrays that capture and interpret neuronal activity related to specific cognitive processes, such as movement intention or communication.

2. What is the market for Implanted Brain-Computer Interface (BCI) Devices?

  • The implanted brain-computer interface (BCI) devices market is estimated to grow at a CAGR of 10.42% during the forecast period from 2025 to 2032.

3. What are the drivers for the Implanted Brain-Computer Interface (BCI) Devices market?

  • The implanted brain-computer interface (BCI) devices market is experiencing significant growth due to several key factors such as the increasing prevalence of neurological and movement disorders and a rising number of patients experiencing hearing and vision loss. Additionally, the growing adoption of digital health solutions is reshaping the landscape of patient care, further fuelling market growth. Key factors contributing to this upward trend include increasing research and development activities and strategic collaborations among leading players to develop more advanced BCI devices.

4. Who are the key players operating in the Implanted Brain-Computer Interface (BCI) Devices market?

  • Some of the key market players operating in the implanted brain-computer interface (BCI) devices market include NeuroPace, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., BrainGate, BrainCo, Inc., Cognixion, Inc., Brain Products GmbH, Compumedics Neuroscan, CorTec, Snap Inc., g.tec medical engineering GmbH, Bitbrain Technologies, Nexstem India Pvt. Ltd., Paradromics, CereGate, Precision Neuroscience, ONWARD Medical N.V., NeuroSky, NeuroXess, and others.

5. Which region has the highest share in the Implanted Brain-Computer Interface (BCI) Devices market?

  • North America is expected to account for the largest market share in the implanted brain-computer interface (BCI) devices market in 2024, out of all regions. This can be attributed to the rising prevalence of hearing loss and neurological disorders, alongside a growing geriatric population. Additionally, increasing healthcare awareness and ongoing technological innovations led by key industry players are significantly driving market growth in North America.

Table of Contents

1. Implanted Brain-Computer Interface (BCI) Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Implanted Brain-Computer Interface (BCI) Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Implanted Brain-Computer Interface (BCI) Devices Market Key Factors Analysis

  • 5.1. Implanted Brain-Computer Interface (BCI) Devices Market Drivers
    • 5.1.1. The increasing prevalence of neurological and movement disorders
    • 5.1.2. Rising number of patients experiencing hearing and vision loss
    • 5.1.3. The growing adoption of digital health solutions
    • 5.1.4. Increasing research and development activities and strategic collaborations among leading players
  • 5.2. Implanted Brain-Computer Interface (BCI) Devices Market Restraints and Challenges
    • 5.2.1. Complications and safety concerns associated with implanted BCI devices
    • 5.2.2. High cost of these devices
  • 5.3. Implanted Brain-Computer Interface (BCI) Devices Market Opportunity
    • 5.3.1. Integration of artificial intelligence (AI) with Implanted BCI devices
    • 5.3.2. Emergence of minimally invasive surgeries and smart implants

6. Implanted Brain-Computer Interface (BCI) Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Implanted Brain-Computer Interface (BCI) Devices Market Assessment

  • 7.1. By Product
    • 7.1.1. Hardware
    • 7.1.2. Software
  • 7.2. By Approach
    • 7.2.1. Invasive BCI
    • 7.2.2. Minimally invasive BCI
  • 7.3. By Application
    • 7.3.1. Epilepsy
    • 7.3.2. Brain Injury
    • 7.3.3. Depression
    • 7.3.4. Stroke
    • 7.3.5. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.3. India Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)

8. Implanted Brain-Computer Interface (BCI) Devices Market Company and Product Profiles

  • 8.1. NeuroPace, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Blackrock Neurotech
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Synchron
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. LivaNova, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. BrainGate
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. BrainCo, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Cognixion, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Brain Products GmbH
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Compumedics Neuroscan
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. CorTec
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Snap Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. g.tec medical engineering GmbH
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Bitbrain Technologies
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Nexstem India Pvt. Ltd.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Paradromics
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. CereGate
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Precision Neuroscience
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. ONWARD Medical N.V.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. NeuroSky
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. NeuroXess
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Implanted Brain-Computer Interface (BCI) Devices Market in Global (2022-2032)
  • Table 3: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Product (2022-2032)
  • Table 4: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Approach (2022-2032)
  • Table 5: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Application (2022-2032)
  • Table 6: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Geography (2022-2032)
  • Table 7: Implanted Brain-Computer Interface (BCI) Devices Market in North America (2022-2032)
  • Table 8: Implanted Brain-Computer Interface (BCI) Devices Market in the United States (2022-2032)
  • Table 9: Implanted Brain-Computer Interface (BCI) Devices Market in Canada (2022-2032)
  • Table 10: Implanted Brain-Computer Interface (BCI) Devices Market in Mexico (2022-2032)
  • Table 11: Implanted Brain-Computer Interface (BCI) Devices Market in Europe (2022-2032)
  • Table 12: Implanted Brain-Computer Interface (BCI) Devices Market in France (2022-2032)
  • Table 13: Implanted Brain-Computer Interface (BCI) Devices Market in Germany (2022-2032)
  • Table 14: Implanted Brain-Computer Interface (BCI) Devices Market in United Kingdom (2022-2032)
  • Table 15: Implanted Brain-Computer Interface (BCI) Devices Market in Italy (2022-2032)
  • Table 16: Implanted Brain-Computer Interface (BCI) Devices Market in Spain (2022-2032)
  • Table 17: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of Europe (2022-2032)
  • Table 18: Implanted Brain-Computer Interface (BCI) Devices Market in Asia-Pacific (2022-2032)
  • Table 19: Implanted Brain-Computer Interface (BCI) Devices Market in China (2022-2032)
  • Table 20: Implanted Brain-Computer Interface (BCI) Devices Market in Japan (2022-2032)
  • Table 21: Implanted Brain-Computer Interface (BCI) Devices Market in India (2022-2032)
  • Table 22: Implanted Brain-Computer Interface (BCI) Devices Market in Australia (2022-2032)
  • Table 23: Implanted Brain-Computer Interface (BCI) Devices Market in South Korea (2022-2032)
  • Table 24: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of the World (2022-2032)
  • Table 26: Implanted Brain-Computer Interface (BCI) Devices Market in the Middle East (2022-2032)
  • Table 27: Implanted Brain-Computer Interface (BCI) Devices Market in Africa (2022-2032)
  • Table 28: Implanted Brain-Computer Interface (BCI) Devices Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Implanted Brain-Computer Interface (BCI) Devices Market in Global (2022-2032)
  • Figure 3: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Product Type (2022-2032)
  • Figure 4: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Approach (2022-2032)
  • Figure 5: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Application (2022-2032)
  • Figure 6: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Geography (2022-2032)
  • Figure 7: Implanted Brain-Computer Interface (BCI) Devices Market in North America (2022-2032)
  • Figure 8: Implanted Brain-Computer Interface (BCI) Devices Market in the United States (2022-2032)
  • Figure 9: Implanted Brain-Computer Interface (BCI) Devices Market in Canada (2022-2032)
  • Figure 10: Implanted Brain-Computer Interface (BCI) Devices Market in Mexico (2022-2032)
  • Figure 11: Implanted Brain-Computer Interface (BCI) Devices Market in Europe (2022-2032)
  • Figure 12: Implanted Brain-Computer Interface (BCI) Devices Market in France (2022-2032)
  • Figure 13: Implanted Brain-Computer Interface (BCI) Devices Market in Germany (2022-2032)
  • Figure 14: Implanted Brain-Computer Interface (BCI) Devices Market in United Kingdom (2022-2032)
  • Figure 15: Implanted Brain-Computer Interface (BCI) Devices Market in Italy (2022-2032)
  • Figure 16: Implanted Brain-Computer Interface (BCI) Devices Market in Spain (2022-2032)
  • Figure 17: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of Europe (2022-2032)
  • Figure 18: Implanted Brain-Computer Interface (BCI) Devices Market in Asia-Pacific (2022-2032)
  • Figure 19: Implanted Brain-Computer Interface (BCI) Devices Market in China (2022-2032)
  • Figure 20: Implanted Brain-Computer Interface (BCI) Devices Market in Japan (2022-2032)
  • Figure 21: Implanted Brain-Computer Interface (BCI) Devices Market in India (2022-2032)
  • Figure 22: Implanted Brain-Computer Interface (BCI) Devices Market in Australia (2022-2032)
  • Figure 23: Implanted Brain-Computer Interface (BCI) Devices Market in South Korea (2022-2032)
  • Figure 24: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Implanted Brain-Computer Interface (BCI) Devices Market in the Rest of the World (2022-2032)
  • Figure 26: Implanted Brain-Computer Interface (BCI) Devices Market in the Middle East (2022-2032)
  • Figure 27: Implanted Brain-Computer Interface (BCI) Devices Market in Africa (2022-2032)
  • Figure 28: Implanted Brain-Computer Interface (BCI) Devices Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis